lncRNA XIST suppresses acute myeloid leukemia progression by promoting necroptosis through the miR-92a-3p/CYLD axis
Cellular Signalling · 2026-11 · 147 · 112744
DOI: 10.1016/j.cellsig.2026.112744 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2026-11. Verfasst von Xianbo Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; Zhejiang Provincial Clinical Resear…. Hauptthemen laut MEDLINE: MicroRNAs, RNA, Long Noncoding, Deubiquitinating Enzyme CYLD, Leukemia, Myeloid, Acute. Die Arbeit nennt 34 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Acute myeloid leukemia (AML) remains a highly lethal hematologic malignancy, with relapse and therapeutic resistance largely driven by apoptosis evasion. Necroptosis, a regulated form of non-apoptotic cell death, has emerged as a potential strategy to eliminate apoptosis-resistant cancer cells; however, its upstream regulatory mechanisms in AML remain incompletely understood. Here, we identify the long non-coding RNA XIST as a previously underappreciated regulator of necroptosis-associated signaling in AML. XIST and CYLD were consistently downregulated in AML cell lines and primary patient samples, whereas miR-92a-3p was upregulated and inversely correlated with XIST and CYLD expression. Clinically, elevated miR-92a-3p expression was associated with inferior overall survival in AML patients. Functionally, endogenous activation of XIST significantly suppressed AML cell proliferation and induced G2/M cell cycle arrest without markedly increasing apoptosis. Instead, XIST overexpression increased membrane-disrupted cell death, as shown by trypan blue and Hoechst/PI staining, and induced necroptosis-like ultrastructural changes. XIST-mediated growth inhibition was partially rescued by the necroptosis inhibitor Necrostatin-1 but not by the pan-caspase inhibitor zVAD-fmk. Moreover, XIST overexpression enhanced CYLD expression and activated necroptosis-associated RIPK1/RIPK3/MLKL signaling, including increased phosphorylation of RIPK1, RIPK3, and MLKL. Mechanistically, XIST directly interacted with miR-92a-3p and negatively regulated its expression, while miR-92a-3p directly targeted CYLD. Inhibition of miR-92a-3p increased CYLD expression and recapitulated the anti-proliferative and necroptosis-associated effects of XIST. In vivo, XIST overexpression suppressed subcutaneous AML xenograft growth and enhanced necroptosis-associated signaling. Collectively, our findings suggest that XIST restrains AML progression, at least in part, by modulating the miR-92a-3p/CYLD axis and promoting necroptosis-associated cell death, highlighting a potential regulatory mechanism for overcoming apoptosis resistance in AML.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China; Zhejiang Provincial Clinical Research Center for Hematological Disorders, Hangzhou, China; Zhejiang Key L…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Huang, X., Chen, Y., Ren, Y., Wang, S., Mei, C., Xu, Y., Jin, J., Tong, H., & Qian, J. (2026). lncRNA XIST suppresses acute myeloid leukemia progression by promoting necroptosis through the miR-92a-3p/CYLD axis. Cellular Signalling, 147, 112744. https://doi.org/10.1016/j.cellsig.2026.112744
Vancouver
Huang X, Chen Y, Ren Y, Wang S, Mei C, Xu Y, et al. lncRNA XIST suppresses acute myeloid leukemia progression by promoting necroptosis through the miR-92a-3p/CYLD axis. Cellular Signalling. 2026;147:112744. doi:10.1016/j.cellsig.2026.112744
BibTeX
@article{Huang2026,
author = {Huang, Xianbo and Chen, Ying and Ren, Yanling and Wang, Shasha and Mei, Chen and Xu, Yu and Jin, Jie and Tong, Hongyan and Qian, Jiejing},
title = {lncRNA XIST suppresses acute myeloid leukemia progression by promoting necroptosis through the miR-92a-3p/CYLD axis},
journal = {Cellular Signalling},
year = {2026},
volume = {147},
pages = {112744},
doi = {10.1016/j.cellsig.2026.112744}
}
EUVIMED